| Autore |
Guandalini Stefano
|
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa |
Cham : , : Springer International Publishing AG, , 2024
|
| Descrizione fisica |
1 online resource (195 pages)
|
| Altri autori (Persone) |
IndrioFlavia
|
| Collana |
Advances in Experimental Medicine and Biology Series
|
| ISBN |
9783031585722
9783031585715
|
| Formato |
Materiale a stampa  |
| Livello bibliografico |
Monografia |
| Lingua di pubblicazione |
eng
|
| Nota di contenuto |
Intro -- Contents -- Shaping Microbiota During the First 1000 Days of Life -- 1 Perinatal Microbial Environment and Its Relevance for Human Health -- 2 Preconception Microbial Environment: Reproductive Microbiota -- 3 Women Microbiota During Pregnancy: What Is Known? -- 3.1 Vaginal Microbiota -- 3.2 Gut Microbiota -- 3.3 Oral Microbiota -- 4 Early Microbiota and Microbial Metabolites Exposition: Where Are We Now? -- 5 Maternal-Neonatal Vertical Transmission: What Is the Scientific Evidence? -- 5.1 Vertical Transmission of Specific Bifidobacterium Members -- 5.2 The Dark Side: Antibiotic Resistance Genes Transfer -- 6 Neonatal Microbiota Establishment and Assembly: What Is Known? -- 6.1 First Pass Neonatal Microbiota: Who Are the Pioneers? -- 6.2 What Are the Factors that Contribute to Infant Microbiota Evolution from Birth to the First Years of Life? -- 7 Tools to Modulate the Maternal-Infant Microbiota During Early Life: From Conception to 2 Years of Life -- 7.1 Impact of Probiotics on Fertility -- 7.2 Probiotics During Gestation -- 7.3 Probiotics During the Postnatal Period: From Birth to Two Years of Life -- 7.4 Prebiotics and Other -Biotics During Gestation and Lactation -- 8 Conclusions -- References -- Necrotizing Enterocolitis and the Preterm Infant Microbiome -- 1 Introduction -- 2 The Human Microbiome -- 3 Basics of the Infant Microbiome -- 4 Preterm Bacterial Colonization Patterns -- 5 The Microbiome and NEC -- 6 Administration of Probiotics to At-Risk Infants to Prevent NEC -- 7 Risks of Administering Probiotics to Premature Infants -- 8 Alternatives for Altering the Infant Microbiome -- 9 Gut-Brain-Axis -- 10 Immunity Connection -- 11 Conclusions and Future Focus -- References -- Can Postbiotics Represent a New Strategy for NEC? -- 1 Introduction -- 2 Necrotizing Enterocolitis and Its Implications.
3 Possible Approaches for NEC Prevention -- 4 Postbiotics Effects on Intestinal Barrier Function and Homeostasis -- 5 Postbiotics Effects in Shaping the Microbiota -- 6 Postbiotics Enhance the Intestinal Barrier -- 7 Immuno-Modulation Activity of Postbiotics -- 8 Conclusions -- References -- Preventing and Treating Colic: An Update -- 1 Introduction -- 2 Etiology -- 2.1 Role of Microbiota -- 3 Probiotics As a Preventive and Therapeutic Strategy -- 3.1 Limosibacterium Reuteri DSM 17938 and Other Lactobacillus Species -- 3.2 Bifidobacterium Species -- 3.3 Probiotic Mixture -- 3.4 Prevention Strategy -- 4 Conclusion -- References -- Targeting Food Allergy with Probiotics -- 1 Introduction -- 2 Main Preclinical Evidence on the Probiotics Efficacy in Food Allergy -- 3 Main Clinical Evidence on the Probiotics Efficacy in Food Allergy -- 3.1 Probiotics for FA treatment -- 3.2 Multi-Strain Formulations for FA -- 3.3 Probiotics to Improve the Outcomes of Oral Immunotherapy -- 4 Conclusions -- References -- Probiotics to Prevent Celiac Disease and Inflammatory Bowel Diseases -- 1 Introduction -- 1.1 The Potential Role of the Human Microbiome in CIDs -- 1.2 Pathogenesis of Celiac Disease and Inflammatory Bowel Diseases -- 1.3 Role of the Microbiome in CeD and IBD -- 1.3.1 Celiac Disease -- 1.3.2 Inflammatory Bowel Disease -- 1.4 Possible Interventions of Probiotics to Manipulate the Microbiome and Challenges for Their Implementation -- 1.5 Use of Probiotics for the Prevention and/or Treatment of CeD and IBD -- 1.5.1 Celiac Disease -- 1.5.2 Inflammatory Bowel Diseases -- 1.6 Prospective Longitudinal Studies as an Ideal Approach to Identify Targets for Disease Prevention through Probiotics: The C... -- 2 Concluding Remarks and Future Directions -- References.
Nutritional Interventions, Probiotics, Synbiotics and Fecal Microbiota Transplantation in Steatotic Liver Disease -- 1 Introduction -- 2 Nutrition, Microbiota and Pediatric MASLD: A Complex Interaction -- 3 The gut-Liver Axis -- 4 Microbiota Composition, Obesity and MASLD -- 5 Metabolic Implications of the Gut Microbiota in MASLD -- 6 Immune Mediated Effect of the gut Microbiota -- 7 Microbiota in Nutritional and Lifestyle Interventions -- 8 Interventions Targeting Microbiota in Pediatric MASLD -- 9 Conclusions -- References -- Probiotics in the Treatment of Inflammatory Bowel Diseases -- 1 Introduction -- 2 Gut Microbiota in IBD -- 3 Probiotic Treatment of Pediatric IBD -- 4 CROHN´S Disease -- 4.1 Induction of Remission -- 4.2 Maintenance of Remission -- 5 Ulcerative Colitis -- 5.1 Inducing Remission -- 5.2 Maintaining Remission -- 6 Conclusions -- References -- Uncategorized References -- Acute Infectious Diarrhea -- 1 Introduction -- 2 Models of Infectious Diarrhea and Mechanisms of Action of Probiotics -- 3 Prevention of Infectious Diarrhea -- 3.1 Children in Hospital Settings -- 3.2 Children in Day-Care Centers -- 4 Treatment of Infectious Diarrhea -- 4.1 Evidence in Low-Income Settings -- 5 Treatment of Covid-Associated Diarrhea -- 6 Conclusions and Future Perspectives -- References -- Probiotics in Functional Gastrointestinal Disorders -- 1 Introduction -- 2 Infantile Colic -- 2.1 Treatment of Infantile Colic with a Focus on Probiotics -- 3 Functional Abdominal Pain and Irritable Bowel Syndrome -- 3.1 Treatment of FAP/IBS with a Focus on Probiotics -- 4 Constipation -- 4.1 Treatment of Functional Constipation with Emphasis on Probiotics -- 5 Conclusion -- References -- Clostridioides difficile Infections: Prevention and Treatment Strategies -- 1 Introduction -- 2 Prevention -- 3 Treatment -- 4 Conclusion -- References.
Current Regulatory Issues for the Use of Probiotics -- 1 Introduction -- 2 Global Regulatory Landscape -- 3 Development of Harmonized Probiotics Guidelines Within Codex Alimentarius -- 4 Labelling Regulations -- 5 Safety -- 6 Conclusion -- References.
|
| Record Nr. | UNINA-9910878045903321 |
Info
Probiotics and Child Gastrointestinal Health : Advances in Microbiology, Infectious Diseases and Public Health Volume 19
